Kerr Drug Director of Finance Salaries in Binghamton, NY | Comparably
Kerr Drug is a pharmacy that sells prescription and over the counter drugs. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
140

Kerr Drug Director of Finance Salaries in Binghamton, NY

The average Kerr Drug Director of Finance in Binghamton, NY earns an estimated $146,917 annually. Kerr Drug's Director of Finance compensation is $15,099 less than the US average for a Director of Finance.

In Binghamton, NY, The Finance Department at Kerr Drug earns $18,315 more on average than the Customer Support Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$146,917
Average Compensation
$146,917
avg. base

Director of Finance Salaries at Kerr Drug

In Binghamton, NY, Directors of Finance earn $26,025 more than Accounting Managers.

Accounting Manager
$121k*
Senior Accountant
$92k*
Business Analyst
$89k*
Financial Analyst
$86k*
Accountant
$71k*
* estimated salary

Compensation at Kerr Drug by Department

In Binghamton, NY, The Finance Department averages $18,315 more than the Customer Support Department, and $9,321 less than the Operations Department

Operations
$91,470 Avg. total comp.
+$9k
Finance
$82,149 Avg. total comp.
Customer Support
$63,834 Avg. total comp.
-$18k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Kerr Drug reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Kerr Drug reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Kerr Drug Rate Their Compensation

The majority of Directors of Finance at Kerr Drug believe they're compensated fairly. 100% of Directors of Finance at Kerr Drug say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Kerr Drug

×
Rate your company